Stada Group
Dr. Theresa M. Thieme is a Senior Manager in Global Project Management at STADA, a position held since December 2010, with prior experience as a Manager in the same field. Previously, Dr. Thieme completed a Student Trainee role in PR, Marketing, and Sales at Degussa AG from October 2005 to October 2006, which involved an internal start-up focused on Degussa Homogeneous Catalysts. Dr. Thieme's educational background includes a Ph.D. in Medicinal Chemistry from the Frankfurt International Research School for Translational Biomedicine (FIRST), completed from 2007 to 2010, and a degree in Chemistry from Goethe University Frankfurt, earned between 2000 and 2010.
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.